Filing Details
- Accession Number:
- 0001209191-14-042021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-17 16:42:33
- Reporting Period:
- 2014-06-13
- Filing Date:
- 2014-06-17
- Accepted Time:
- 2014-06-17 16:42:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1000694 | Novavax Inc | NVAX | Biological Products, (No Disgnostic Substances) (2836) | 222816046 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1468534 | John Trizzino | C/O Novavax, Inc. 20 Firstfield Road Gaithersburg MD 20878 | Svp, Commercial Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-13 | 11,000 | $4.47 | 11,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-06-16 | 4,800 | $4.59 | 15,800 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-06-16 | 700 | $4.59 | 16,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |